UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

CURRENT REPORT

 

FORM 8-K

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act

 

Date of Report (Date of Earliest Event Reported): March 17, 2015

 

Hanger, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware
(State or other jurisdiction of

 

1-10670
(Commission File Number)

 

84-0904275
(IRS Employer Identification

incorporation

 

 

 

No.)

 

10910 Domain Drive, Suite 300
Austin, Texas 78758

 (Address of principal executive offices (zip code))

 

(512) 777-3800

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 

o             Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o             Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a - 12)

 

o             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o             Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13d-4(c))

 

 

 



 

Item 1.01                                            Entry into a Material Definitive Agreement.

 

On March 17, 2015, Hanger, Inc. (the “Company”) entered into an agreement that modified its Credit Agreement (the “Credit Agreement”) dated as of June 17, 2013 among the Company, the lenders from time to time party thereto and Bank of America, N.A., as administrative agent (the “Agent”).  As described below, this agreement (the “Agreement”) waives actual or potential defaults and events of default under the Credit Agreement and also modifies the amount that the Company can borrow under the revolving loan facility under the Credit Agreement from $200 million to $146.3 million.  This modification arose in connection with discussions between the Company and its lenders regarding, among other things, the adverse impact of the implementation of Janus, the Company’s new patient management and billing system for the Company’s Hanger Clinic business, on cash collections and accounts receivable balances in the second half of 2014, as described in more detail below.  Prior to entry into the Agreement, the Company had been working with the Agent and the lenders under the Credit Agreement to waive certain actual or potential defaults and events of default under the Credit Agreement.

 

On December 12, 2014, the Company, the lenders and the Agent entered into a waiver to the Credit Agreement to, among other things, waive any default or event of default under the Credit Agreement arising from (a) the Company’s failure to deliver to the Agent certain financial information and other materials for the period ended September 30, 2014 (the “Third Quarter Financial Information”) and (b) the Company’s failure to timely furnish its Quarterly Report on Form 10-Q for the quarter ended September 30, 2014 to the holders of the notes and the trustee under the Indenture (the “Indenture”) dated as of November 2, 2010 among the Company, certain of the Company’s subsidiaries and Wilmington Trust Company, as trustee (the “Trustee”).  This waiver was in effect until the earlier to occur of delivery of the Third Quarter Financial Information to the Agent and the close of business on January 15, 2015.  On January 14, 2015, the Company, the lenders and the Agent entered into a second waiver to the Credit Agreement to, among other things, extend the expiration date to the earliest to occur of delivery of the Third Quarter Financial Information to the Agent, the close of business on March 17, 2015 or an occurrence of any event of default under the Indenture.

 

In anticipation of the expiration of the second waiver to the Credit Agreement, Hanger has entered into the Agreement. The Agreement, which is called Waiver No. 3, waives, among other things, any default or event of default under the Credit Agreement arising from (a) the Company’s failure to deliver to the Agent certain financial information and other materials for the periods ended September 30, 2014, December 31, 2014 and March 31, 2015 (the “Annual and Quarterly Financial Information”), (b) the restatement of, or revision or adjustment to, certain previously furnished annual and quarterly consolidated financial statements as described in more detail in that certain Current Report on Form 8-K filed by the Company on February 17, 2015 and the resulting inaccuracies of certain representations and warranties in the Credit Agreement, and (c) the Company’s failure to timely furnish its Quarterly Reports on Form 10-Q for the quarters ended September 30, 2014 and March 31, 2015 and its Annual Report on Form 10-K for the period ended December 31, 2014 to the holders of the notes and the Trustee under the Indenture.  These defaults and events of default are waived until the earliest to occur of (i) delivery of the Annual and Quarterly Financial Information to the Agent (the “Compliance Date”), (ii) the close of business on August 17, 2015, and (iii) thirty days after the date on which, pursuant to the Indenture, written notice in respect of the Company’s failure to furnish certain financial information to the holders of the notes and the Trustee under the Indenture has been given to the Company (the “New Expiration Date”).

 

The Agreement also waives until the earlier to occur of the New Expiration Date and May 31, 2015 any default or event of default under the Credit Agreement arising from, among other things, the inaccuracy of representations and warranties in the Credit Agreement relating to certain inventory related adjustments.

 

2



 

Until the Compliance Date, the amount that the Company can borrow under the Credit Agreement in the form of revolving loans, swing line loans and/or letters of credit has been reduced from $200 million to $146.3 million.  On March 18, 2015 the Company had $146.3 million drawn on the revolving credit line and approximately $48 million of cash on hand, and believes it has sufficient liquidity to meet operating needs and planned capital expenditures through the remainder of the year.

 

The Agreement was a result of discussions between the Company and its lenders regarding the Company’s continuing delay in filing periodic reports with the Securities and Exchange Commission and a reduction in the Company’s cash flows resulting from operating issues arising in connection with the implementation of Janus, a new patient management and billing system for the Company’s Hanger Clinic business.

 

The Company has not yet filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2014 or its Annual Report on Form 10-K for the year ended December 31, 2014.  Although the Company has added significant external accounting resources, it nevertheless believes that it will likely not be able to timely file its Quarterly Report on Form 10-Q for the first quarter ended March 30, 2015 due primarily to its continuing efforts to complete its 2014 annual inventory valuation, its requirement to file restated consolidated financial statements as identified in and for the reasons described in its Current Report on Form 8-K filed February 17, 2015, and the completion of the audit of its 2014 consolidated financial statements.

 

Additionally, the Company’s cash collections and accounts receivable balances have been adversely impacted by the implementation of Janus.  In connection with this implementation, the Company encountered workflow constraints and issues associated with the centralization of cash deposit and application functions, contributing to slower rates of collections and an increase in unapplied cash balances.  This in turn has led to an increase in accounts receivable balances and the aging of those balances.  To respond to these issues, the Company halted the implementation of the Janus system in the third quarter of 2014.  The Company also significantly increased its allowances for contractual adjustments and for doubtful accounts by an aggregate of approximately $38 million in 2014, of which approximately $29 million was recorded in the second half of the year, primarily as a result of the issues arising in the implementation of Janus.  Janus is now installed and operating at approximately one third of Hanger Clinic’s locations.  To address the issues that have arisen, the Company is implementing workflow and system modifications, and has added internal and external resources to improve collections. The Company’s estimates of its increase in allowances for contractual adjustments and for doubtful accounts are based on currently available and evaluated information and are preliminary and subject to change.

 

The foregoing description of the Agreement is qualified in its entirety by reference to the Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K.

 

Item 8.01                                            Other Events.

 

The Company filed a Current Report on Form 8-K on February 17, 2015 that, among other things, disclosed that, in the fourth quarter of 2014, in connection with ongoing remediation efforts undertaken to address previously identified material weaknesses related to inventory, it implemented new estimation methods, processes and controls to refine the manner in which it values raw materials and work-in-process inventory at Hanger Clinic. The Company has completed a preliminary calculation of the value of its work-in-process inventory at December 31, 2014, and the preliminary, unaudited estimated value is materially less than the carrying value for that inventory calculated under the previous estimation method.  The resulting inventory valuation adjustment is expected to have a material adverse effect on

 

3



 

the value of the Company’s overall inventory at December 31, 2014, and on the Company’s reported earnings and financial results for the quarter and year ended December 31, 2014, but is not expected to affect operating cash flows for those periods.  The Company is in the process of determining the impact of the inventory valuation adjustment to prior periods, and the resulting inventory valuation adjustments may have a material adverse effect on overall inventory values and reported earnings and financial results for one or more prior periods.  The Company’s estimates are based on currently available and evaluated information and are preliminary and subject to change.

 

Disclosures About Forward-Looking Statements

 

This Form 8-K contains certain “forward-looking statements” relating to the Company. All statements, other than statements of historical fact included herein, are “forward-looking statements,” including statements regarding the timing of filing of, and the outcome of the Company’s work in connection with, completing certain financial statements and other financial data. These forward-looking statements are often identified by the use of forward-looking terminology such as “intends,” “expects” or similar expressions and involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this filing.  The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. These uncertainties include, but are not limited to, the risk that additional information may arise during the course of the Company’s ongoing accounting review that would require the Company to make additional adjustments or revisions to its estimates or financial statements or to restate further its consolidated financial statements and other financial data for current or historical periods, the time required to complete the consolidated financial statements and other financial data and accounting review as well as the time required to prepare its periodic reports for filings with the Securities and Exchange Commission.  For additional information and risk factors that could affect the Company, see its Form 10-K for the year ended December 31, 2013 as filed with the Securities and Exchange Commission as well as the risk factor set forth in Item 8.01 of the Company’s Current Report on Form 8-K filed February 17, 2015. The information contained in this filing is made as of the date hereof, even if subsequently made available by the Company on its website or otherwise.

 

Item 9.01                                            Financial Statements and Exhibits.

 

(d) Exhibits.

 

10.1                               Waiver No. 3 dated as of March 17, 2015 among Hanger, Inc., the lenders party thereto and Bank of America, N.A., as Administrative Agent.

 

4



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

HANGER, INC.

 

 

 

 

 

By:

/s/ Thomas E. Hartman

 

 

Thomas E. Hartman

 

 

Vice President and General Counsel

 

 

 

Dated: March 23, 2015

 

 

5



 

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

10.1

 

Waiver No. 3 dated as of March 17, 2015 among Hanger, Inc., the lenders party thereto and Bank of America, N.A., as Administrative Agent.

 

6


Exhibit 10.1

 

WAIVER NO. 3

 

WAIVER No. 3 (this “ Waiver No. 3 ”), dated as of March 17, 2015, to that certain Credit Agreement, dated as of June 17, 2013 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time prior to the date hereof, the “ Credit Agreement ”; capitalized terms used herein and not defined shall have the meaning set forth in the Credit Agreement), among HANGER, INC. (the “ Borrower ”), each lender from time to time party thereto (collectively, the “ Lenders ” and individually, a “ Lender ”), and BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and Issuer.

 

W I T N E S S E T H :

 

WHEREAS, pursuant to Section 11.01 of the Credit Agreement, on December 12, 2014 (as further modified and continued on January 14, 2015 by Waiver No. 2 to the Credit Agreement) (the “ Existing Waivers ”), the Borrower and the Required Lenders agreed to the waiver of certain of the terms of the Credit Agreement and other Loan Documents.

 

WHEREAS, pursuant to Section 11.01 of the Credit Agreement, the Borrower and the Lenders party hereto agree to the further waiver of certain of the terms of the Credit Agreement and other Loan Documents as set forth herein.

 

NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:

 

SECTION ONE - Waiver .  Subject to the satisfaction of the conditions set forth in Section Two hereof, the Required Lenders hereby waive until the Expiration Date (as defined below), (a) any Default or Event of Default under Section 9.01(d) and Section 9.01(b) of the Credit Agreement, to the extent such Default or Event of Default arises or has arisen in connection with (i) the Borrower’s obligations under (A) Section 7.01(a) in respect of the financial information and other materials required to be delivered pursuant thereto for the period ended December 31, 2014, and (B) Section 7.01(b) in respect of the financial information and other materials required to be delivered pursuant thereto for the periods ended September 30, 2014 and March 31, 2015, as well as, in each case under this clause (i) in respect thereto, the requirement to give any notice pursuant to Section 7.03 and to deliver a Compliance Certificate pursuant to Section 7.02(b), (ii) the restatement of, or revision or adjustment to, the annual and/or quarterly consolidated financial statements substantially consistent with accounting adjustments specified in Item 4.02 of the Borrower’s Current Report on Form 8-K filed on February 17, 2015 (other than under the caption “Additional Accounting Review and Financial Statement Preparation”) (the “ Review Report ”), (iii) the inaccuracy of any representation or warranty, including Section 6.11 and Section 6.21, contained in the Loan Documents solely as a result of or in connection with the matters referred to in clause (ii) above and (iv) any action taken or any failure to take action while any Default or Event of Default resulting from clause (iii) above was continuing, to the extent such action or failure to take action would have been permitted but for the existence of such Default or Event of Default, including any request for any Loan (or any conversion or continuation with respect thereto) or Issuance of any Letter of Credit

 



 

after the occurrence and during the continuance of any such Default or Event of Default and (b) any Default under Section 9.01(e)(ii) to the extent such Default arises or has arisen as a result of the Borrower’s failure to timely furnish its (i) Quarterly Reports on Form 10-Q for the quarters ended September 30, 2014 and March 31, 2015 and (ii) Annual Report on Form 10-K for the period ended December 31, 2014, in each case, to the holders of the notes and the Trustee (as defined below) under the Indenture (as defined below).  Furthermore, subject to the satisfaction of the conditions set forth in Section Two hereof, the Required Lenders hereby waive until the earliest of the Expiration Date and May 31, 2015, any Default or Event of Default under Section 9.01(b) of the Credit Agreement, to the extent such Default or Event of Default arises or has arisen in connection with (a) the inaccuracy of any representation or warranty, including Section 6.11 and Section 6.21, contained in the Loan Documents solely as a result of or in connection with any inventory related adjustments in connection with the ongoing review thereof described under the caption “Additional Accounting Review and Financial Statement Preparation” in the Review Report and (b) any action taken or any failure to take action while any Default or Event of Default resulting from clause (a) above was continuing, to the extent such action or failure to take action would have been permitted but for the existence of such Default or Event of Default, including any request for any Loan (or any conversion or continuation with respect thereto) or Issuance of any Letter of Credit after the occurrence and during the continuance of any such Default or Event of Default.  “ Expiration Date ” shall mean the date of the earliest to occur of (w) compliance with Sections 7.01(a), 7.01(b) and 7.02(b) (the “Compliance Date”), (x) the close of business on August 17, 2015, (y) thirty (30) days after the date on which, pursuant to that certain Indenture, dated as of November 2, 2010 (the “ Indenture ”), among the Borrower, certain of the Borrower’s subsidiaries and Wilmington Trust Company, as trustee (the “ Trustee ”), written notice (the “ Default Notice ”) in respect of the Borrower’s failure to perform or comply with Section 4.03 of the Indenture has been given to the Borrower by the Trustee or to the Borrower and the Trustee by the holders of at least 25% in the aggregate principal amount of the outstanding notes under the Indenture (and, for the avoidance of doubt, for purposes of complying with Section 7.03(a), the Borrower shall notify the Administrative Agent of the giving of such Default Notice on the next succeeding Business Day); provided that from the date hereof and until the Compliance Date, no Credit Extensions shall be permitted without the consent of the Required Lenders unless (i) no Default Notice has been given and (ii) after giving effect to any such Credit Extension, the Outstanding Amount of all Revolving Loans, Swing Line Loans and L/C Obligations, taken together, would not exceed $146.3 million, and (z) an occurrence of any event of default under and as defined in the Indenture.  It is understood and agreed that, unless the Compliance Date has occurred, the foregoing and all other prior Existing Waivers shall be null and of no effect on and following the Expiration Date.  It is further understood and agreed that, unless the Compliance Date has occurred, on or prior to the 15th day of each month, the Borrower shall participate in conference calls with Lenders to provide updates in connection with the foregoing matters as well as financial updates and updates on the Borrower’s cash position.

 

SECTION TWO - Conditions to Effectiveness .  This Waiver No. 3 shall become effective (the “ Waiver No. 3 Effective Date ”) upon satisfaction of each of the following conditions:

 

(a)                             the Administrative Agent shall have received counterparts hereof signed by each of the Required Lenders and the Borrower;

 

2



 

(b)                             after giving effect to this Waiver No. 3, no Default or Event of Default will have occurred and be continuing on such date;

 

(c)                              the Administrative Agent shall have received a certificate of a Responsible Officer of the Borrower as to the satisfaction of the condition set forth in Section 2(b).

 

(d)                             All fees and expenses payable on or before the date hereof by the Borrower to the Administrative Agent (or its Affiliates) in connection with this Waiver No. 3 in accordance with Section 11.04 of the Credit Agreement and/or the Lenders (or their respective Affiliates) pursuant to this Waiver No. 3 shall have been paid, including the reasonable fees, charges and disbursements of counsel for the Administrative Agent, to the extent invoiced to the Borrower prior to the date hereof.

 

SECTION THREE — Consent Fee .  Each Lender under the Credit Agreement who submits a signature page to this Waiver No. 3 to the Administrative Agent shall receive a non-refundable fee equal to 0.10% of the aggregate principal amount of its Loans and/or Commitments immediately prior to the Waiver No. 3 Effective Date, which fee will be earned on the Waiver No. 3 Effective Date and due and payable in full on the next succeeding Business Day.

 

You agree that once paid, the fees or any part thereof payable under this Waiver No. 3 will not be refundable under any circumstances. All fees payable under this Waiver No. 3 will be paid in immediately available funds and shall be in addition to any reimbursement of expenses to the extent reimbursable pursuant to this Waiver No. 3.  All amounts payable under this Waiver No. 3 will be made in United States dollars and shall not be subject to counterclaim or set-off for, or be otherwise affected by, any claim or dispute relating to any other matter. In addition, all such payments shall be made without deduction for any taxes, levies, imposts, duties, deductions, charges or withholdings imposed by any national, state or local taxing authority, or will be grossed up by the Borrower for such amounts.

 

SECTION FOUR - Governing Law .  This Waiver No. 3 shall be governed by, and construed in accordance with, the law of the State of New York.

 

SECTION FIVE — Full Force and Effect .  Except as expressly set forth herein, this Waiver No. 3 shall not by implication or otherwise limit, impair, constitute a waiver of or otherwise affect the rights and remedies of the Lenders or the Administrative Agent under the Credit Agreement or any other Loan Document, and shall not alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other provision of the Credit Agreement or any other Loan Document, all of which are ratified and affirmed in all respects and shall continue in full force and effect.

 

SECTION SIX — Counterparts .  This Waiver No. 3 may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.

 

[SIGNATURE PAGE FOLLOWS]

 

3



 

IN WITNESS WHEREOF, the parties hereto have caused this Waiver No. 3 to be duly executed and delivered as of the day and year first above written.

 

 

HANGER, INC.

 

 

 

 

 

By:

/s/ Thomas E. Kiraly

 

 

Name:

Thomas E. Kiraly

 

 

Title:

Executive Vice President and

 

 

 

Chief Financial Officer

 

[Hanger Waiver No. 3]

 



 

Acknowledged and consented to

 

as of the date first set forth above:

 

 

 

BANK OF AMERICA, N.A.,

 

as Administrative Agent

 

 

 

By:

/s/ Christine Trotter

 

 

Name:

Christine Trotter

 

 

Title:

Assistant Vice President

 

 

 

BANK OF AMERICA, N.A.,

 

as Issuer and Swing Line Lender

 

 

 

By:

/s/ Whitney M. Fraga

 

 

Name:

Whitney M. Fraga

 

 

Title:

Senior Vice President

 

 

[Hanger Waiver No. 3]

 



 

 

Bank of America N.A.,

 

as a Lender (type name of the legal entity)

 

 

 

By:

/s/ Whitney M. Fraga

 

 

Name:

Whitney M. Fraga

 

 

Title:

Senior Vice President

 

[Hanger Waiver No. 3]

 



 

 

SunTrust Bank,

 

as a Lender (type name of the legal entity)

 

 

 

By:

/s/ Mary E. Coke

 

 

Name:

Mary E. Coke

 

 

Title:

Vice President

 

[Hanger Waiver No. 3]

 



 

 

BRANCH BANKING AND TRUST COMPANY,

 

as a Lender (type name of the legal entity)

 

 

 

By:

/s/ Janet L. Wheeler

 

 

Name:

Janet L. Wheeler

 

 

Title:

Vice President

 

[Hanger Waiver No. 3]

 



 

 

COMPASS BANK,

 

as a Lender (type name of the legal entity)

 

 

 

 

 

By:

/s/ D. Sowards

 

 

Name:

Debbie Sowards

 

 

Title:

Sr. Vice President

 

[Hanger Waiver No. 3]

 



 

 

Wells Fargo Bank National Association,

 

as a Lender (type name of the legal entity)

 

 

 

 

 

By:

/s/ Kirk Tesch

 

 

Name:

Kirk Tesch

 

 

Title:

Managing Director

 

[Hanger Waiver No. 3]

 



 

 

Royal Bank of Canada,

 

as a Lender (type name of the legal entity)

 

 

 

 

 

By:

/s/ Amy S. Promaine

 

 

Name:

Amy Promaine

 

 

Title:

Authorized Signatory

 

[Hanger Waiver No. 3]

 



 

 

Sumitomo Mitsui Banking Corporation,

 

as a Lender (type name of the legal entity)

 

 

 

 

 

By:

/s/ Shuji Yabe

 

 

Name:

Shuji Yabe

 

 

Title:

Managing Director

 

[Hanger Waiver No. 3]

 



 

 

BOKF, NA dba Bank of Texas,

 

as a Lender (type name of the legal entity)

 

 

 

 

 

By:

/s/ Chris O’Brien

 

 

Name:

Chris O’Brien

 

 

Title:

Vice President

 

[Hanger Waiver No. 3]

 



 

 

Fifth Third Bank,

 

as a Lender (type name of the legal entity)

 

 

 

 

 

By:

/s/ Thomas Avery

 

 

Name:

Thomas Avery

 

 

Title:

Relationship Manager

 

[Hanger Waiver No. 3]

 



 

 

ASSOCIATED BANK, N.A.,

 

as a Lender (type name of the legal entity)

 

 

 

 

 

By:

/s/ James A. Goody

 

 

Name:

James A. Goody

 

 

Title:

Vice President

 

[Hanger Waiver No. 3]

 



 

 

Regions Bank,

 

as a Lender (type name of the legal entity)

 

 

 

 

 

By:

/s/ Robert B. Harrington

 

 

Name:

Robert B. Harrington

 

 

Title:

Vice President

 

[Hanger Waiver No. 3]